A backlog of Patent Trial and Appeal Board appeals is building up at the Federal Circuit. Finnegan’s Erika Arner discusses recent decisions of interest, including the appeals court affirming the invalidation of two patents cited in the creation of the covered business method patent programme
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the Danish company’s injunction application